Literature DB >> 19592361

Role of cognition and priming in interlimb generalization of adaptive control of gait stability.

Tanvi Bhatt1, Yi-Chung Pai.   

Abstract

The authors examined the impact of (a) awareness of impending slip and (b) priming (to accelerate learning) on interlimb transfer of acquired stability control. Among the participants, 12 of 24 young individuals were not informed of 2 impending slips on the nontrained left-side (UNWARN), whereas the other 12 knew the exact timing and location of the 1st left slip (WARN) following 24 right-side slips, given to all participants while walking. Both groups reduced the backward loss of balance (BLOB) incidence from 100% on the first slip to 0% on 24th slip. The authors found significantly better transfer of the improved stability control in WARN than in UNWARN, resulting in a greater reduction in BLOB on the 1st left slip (55% vs. 92%, respectively). The priming was evident with no BLOB on the 2nd left slip versus 50% on the 2nd right slip. Thus, the interlimb generalization can be improved by cognition and evidenced in priming.

Entities:  

Mesh:

Year:  2009        PMID: 19592361     DOI: 10.3200/35-08-021

Source DB:  PubMed          Journal:  J Mot Behav        ISSN: 0022-2895            Impact factor:   1.328


  3 in total

1.  Interlimb transfer of motor skill learning during walking: No evidence for asymmetric transfer.

Authors:  Chandramouli Krishnan; Rajiv Ranganathan; Manik Tetarbe
Journal:  Gait Posture       Date:  2017-04-27       Impact factor: 2.840

2.  Which Are the Key Kinematic and Kinetic Components to Distinguish Recovery Strategies for Overground Slips Among Community-Dwelling Older Adults?

Authors:  Shuaijie Wang; Yiru Wang; Yi-Chung Clive Pai; Edward Wang; Tanvi Bhatt
Journal:  J Appl Biomech       Date:  2020-06-03       Impact factor: 1.833

3.  Can prior exposure to repeated non-paretic slips improve reactive responses on novel paretic slips among people with chronic stroke?

Authors:  Shamali Dusane; Tanvi Bhatt
Journal:  Exp Brain Res       Date:  2022-02-01       Impact factor: 2.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.